Related Experiment Video
Updated: Feb 10, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations
Angelo Sangiovanni1, Michela Triolo2, Massimo Iavarone1
1Division of Gastroenterology and Hepatology, CRC "A.M. and A. Migliavacca" Center for the study of Liver Disease, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Insights
Standard hepatocellular carcinoma (HCC) guidelines need refinement. Personalized treatment plans improved survival for patients not fitting standard criteria, suggesting guidelines require updates for better HCC management.
Area of Science:
- Hepatology
- Oncology
- Clinical Medicine
Background:
- Standardized protocols for hepatocellular carcinoma (HCC) management exist but require real-world validation.
- The applicability and efficacy of established guidelines in clinical practice are under scrutiny.
Purpose of the Study:
- To evaluate the practical application and effectiveness of American Association for the Study of Liver Diseases (AASLD) guidelines for HCC treatment.
- To assess guideline adherence and patient outcomes across different stages of HCC.
Main Methods:
- A cohort of 370 cirrhotic patients with de novo HCC, stratified by Barcelona Clinic Liver Cancer (BCLC) stage (A, B, C), were treated based on multidisciplinary team decisions.
- Treatment adherence to AASLD recommendations was recorded, and patient outcomes, including radiological response and mortality rates, were tracked.
Main Results:
- AASLD guideline adherence varied by BCLC stage (81% for A, 54% for B, 53% for C).
- Complete radiological response rates were 45% after first-line, 19% after second-line, and 23% after third-line treatment.
- Adherence to AASLD guidelines correlated with lower mortality in BCLC A, while treatment upstaging improved survival in BCLC B and C.
Conclusions:
- Multimodality HCC treatment beyond first-line therapy is frequent and impacts complete response rates.
- Personalized treatment strategies offer survival advantages for patients outside standard guideline profiles.
- International HCC recommendations require amendment to better incorporate diverse patient profiles and improve outcomes.
Background:
Management of hepatocellular carcinoma (HCC) is framed within standardized protocols released by Scientific Societies, whose applicability and efficacy in field practice need refining.
Aim:
We evaluated the applicability and effectiveness of guidelines for the treatment of HCC of the American Association for the Study of the Liver (AASLD).
Methods:
370 consecutive cirrhotic patients with de novo HCC in different stages, 253 BCLC A, 66 BCLC B, 51 BCLC C received treatment through a multidisciplinary team (MDT) decision and were followed until death or end of follow-up.
Results:
Treatment was adherent to AASLD recommendations in 205 (81%) BCLC A patients, 36 (54%) BCLC B, and 27 (53%) BCLC C. Radiological complete response was achieved in 165 (45%) patients after the first-line treatment, in 22 (19%) after a second-line and in 9 (23%) after a third-line treatment. Adherence to AASLD recommendation allowed a lower yearly mean mortality rate in BCLC A patients compared with other treatment (5.0% vs 10.4% P = .004), whereas upward treatment stage migration compared with the standard of care was associated with reduced yearly mortality in BCLC B (8.6% vs 20.7%, P = .029) and BCLC C (42.6% vs 59.0%, P = .04) patients.
Conclusions:
HCC multimodality treatment including other than first-line therapy is common in clinical practice and impact on the achievement of complete response. Personalized treatment was able to provide survival benefits to patients whose profile is not accounted for by international recommendations, which need to be amended.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
05:31Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Related Concept Videos
Internal Energy
Internal Energy
Internal Receptors
International System of Units
Prefixes are used to define both larger and smaller quantities in the SI system. For example, milli, micro, and nano define smaller quantities, while kilo, mega, and giga are used to define...
Characteristics of Practical Op Amps
The ratio of differential gain to the common-mode gain is defined as the common-mode rejection ratio (CMRR). This ratio quantifies the ability of operational amplifiers (op-amps) to reject common-mode...
Theoretical Foundations of Nursing Practice
Theories provide a perspective to assess patients' conditions and organize data and methods. They also assist in analyzing and interpreting information. They represent a...